Related Experiment Videos
Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis
D Rost1, J Kartenbeck, D Keppler
1Division of Tumor Biochemistry, Deutsches Krebsforschungszentrum, Heidelberg, Germany.D.Rost@dkfz-heidelberg.de
Abstract:
Administration of phalloidin, one of the toxic peptides of the mushroom Amanita phalloides, leads to rapid and sustained cholestasis in rats. Although attributed to the interaction of phalloidin with microfilaments, the events leading to cholestasis are incompletely understood. The adenosine triphosphate (ATP)-dependent, apical conjugate export pump, termed multidrug resistance protein 2 (Mrp2) or canalicular multispecific organic anion transporter, is the major driving force for bile salt-independent bile flow. We investigated the role of Mrp2 in phalloidin-induced cholestasis. Bile flow decreased to 53% and 31% of control at 15 and 30 minutes after phalloidin (0.5 mg/kg), respectively. Mrp2-mediated [3H]leukotriene excretion into bile during the initial 45 minutes was reduced to 44% of control when [3H]LTC4 was injected 15 minutes after phalloidin treatment. Mrp2 was progressively lost from the hepatocyte canalicular membrane and detected predominantly on intracellular membrane structures together with other canalicular proteins including P-glycoproteins, ecto-ATPase, and dipeptidyl-peptidase IV. By contrast, structures involved in intercellular adhesion (zonula occludens, zonula adhaerens, and desmosomes) as well as intermediate filaments of the cytokeratin type appeared largely unaffected within 30 minutes after phalloidin. In line with the immunofluorescence analysis, immunoblots indicated a loss of Mrp2 and P-glycoproteins from the canalicular membrane and a 3- and 4.6-fold increase of these transport proteins in the microsomal fraction, respectively. Our results indicate that phalloidin induces marked alterations of the hepatocyte canalicular architecture and a loss of Mrp2 together with other proteins from the canalicular membrane. The resulting cholestasis can therefore be explained in part by the loss of export pumps, including Mrp2, from the canalicular membrane.
Insights
Phalloidin causes liver cholestasis by disrupting hepatocyte canalicular architecture. This toxin leads to the loss of essential export pumps, like multidrug resistance protein 2 (Mrp2), from the cell membrane, impairing bile flow.
Area of Science:
- Hepatology
- Toxicology
- Cell Biology
Background:
- Phalloidin, a toxin from Amanita phalloides, induces cholestasis, but the underlying mechanisms are not fully understood.
- Multidrug resistance protein 2 (Mrp2) is crucial for bile salt-independent bile flow via ATP-dependent apical conjugate export.
Purpose of the Study:
- To investigate the role of Mrp2 in phalloidin-induced cholestasis in rats.
- To elucidate the effects of phalloidin on hepatocyte canalicular membrane proteins.
Main Methods:
- Rats were administered phalloidin (0.5 mg/kg) and bile flow was measured.
- Mrp2-mediated leukotriene excretion was assessed using [3H]LTC4.
- Immunofluorescence and immunoblotting were used to analyze the localization and expression of Mrp2 and other canalicular proteins.
Main Results:
- Phalloidin significantly reduced bile flow and Mrp2-mediated leukotriene excretion.
- Mrp2 and P-glycoproteins were progressively lost from the canalicular membrane and accumulated in intracellular fractions.
- Intercellular adhesion structures and cytokeratin filaments remained largely unaffected.
Conclusions:
- Phalloidin disrupts hepatocyte canalicular architecture, causing cholestasis.
- The loss of Mrp2 and other export pumps from the canalicular membrane contributes to phalloidin-induced cholestasis.